Results 201 to 210 of about 13,286,607 (333)

A New Design of Metamaterials for SAR Reduction [PDF]

open access: gold, 2013
Mohammad Rashed Iqbal Faruque   +2 more
openalex   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

Assessing the ECHO<sup>®</sup> model's role in strengthening health department responses to dementia risk. [PDF]

open access: yesFront Public Health
Roberts SS   +9 more
europepmc   +1 more source

Reactivity of redox cycled Fe-bearing subsurface sediments towards hexavalent chromium reduction

open access: green, 2019
Michael E. Bishop   +8 more
openalex   +2 more sources

Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study

open access: green, 2021
Linda Fernandes   +5 more
openalex   +2 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy